Protein aggregation is not the cause of neurodegeneration—it is a symptom of failing proteostasis

We have spent decades targeting protein aggregates in neurodegenerative disease. Amyloid plaques in Alzheimer's. Lewy bodies in Parkinson's. TDP-43 inclusions in ALS. The assumption was that these aggregates are toxic and removing them would help.
The emerging picture is different. The aggregates themselves are not the primary problem. They are the visible manifestation of a deeper failure: the collapse of cellular proteostasis.